Severe hidradenitis suppurative in an HIV-positive male: Use of multiple treatment modalities, including tumor necrosis factor blockade

AIDS Patient Care and STDs

Volumn 25, Issue 9, 2011, Pages 507-508

  Husein Elahmed, Husein ^a   Fernandez Pugnaire, Maria Antonia ^a   Ruiz Carrascosa, Jose Carlos ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; C REACTIVE PROTEIN; CEFALEXIN; CIPROFLOXACIN; ERYTHROMYCIN; INFLIXIMAB; ISOTRETINOIN; LAMIVUDINE; TETRACYCLINE; ZIDOVUDINE;

ADULT; CASE REPORT; EDITORIAL; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOW LEVEL LASER THERAPY; MALE; SUPPURATIVE HIDRADENITIS; VIRUS LOAD;

ANTI-HIV AGENTS; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; DERMATOLOGIC AGENTS; HIDRADENITIS SUPPURATIVA; HIV INFECTIONS; HUMANS; LASER THERAPY; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80051998403     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2011.0158     Document Type: Editorial

References (11)

1. Fardet L, Dupuy A, Kerob D, et al. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients. J Am Acad Dermatol 2007;56:624-628. (Pubitemid 46400174)
2. Shah N. Hidradenitis suppurativa: A treatment challenge. Am Fam Physician 2005;72:1547-1552.
3. Papadopoulos AJ, Kihiczak G, Schwartz RA. Hidradenitis suppurativa. An update. Acta Dermatovenerol Alp Panonica Adriat 2000;9:xx-xx.
4. Padberg J, Schormann D, Grobusch M, Bergmann F. Drug interaction of isotretinoin and protease inhibitors: Support for the cellular retinoic acid-binding protein-1 theory of lipodystrophy. AIDS 1999;13:284-285. (Pubitemid 29050420)
5. Khambhati R, Singhal P, Marfatia YS. Hidradenitis suppurativa in AIDS. Indian J Sex Transm Dis [serial online] 2010 [cited 2011 May 6];31:45-46.
6. Unachukwu CN, Uchenna DI, Young EE. Endocrine and metabolic disorders associated with human immune deficiency virus infection.West Afr J Med 2009;28:3-9.
7. Mayo J, Collazos J, Mart?nez E, Ibarra S. Adrenal function in the human immunodeficiency virus-infected patient. Arch Intern Med 2002;162:1095-1098. (Pubitemid 34522393)
8. Haslund P, Lee RA, Jemec GB. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors. Acta Derm Venereol 2009;89:595-600.
9. Brunasso AM, Massone C. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors: An update on infliximab. Acta Derm Venereol 2011;91:70-71.
10. Alecsandru D, Padilla B, Izquierdo JA, Fernández-Cruz E, Sánchez-Ramón S. Severe refractory hidradenitis suppurativa in an HIV-positive patient successfully treated with infliximab. Arch Dermatol 2010;146:1343-1345.
11. Xu LY, Wright DR, Mahmoud BH, Ozog DM, Mehregan DA, Hamzavi IH. Histopathologic study of hidradenitis suppurativa following long-pulsed 1064-nm Nd:YAG laser treatment. Arch Dermatol 2011;147:21-28.